Cargando…

Identification of potent compounds against SARs-CoV-2: An in-silico based drug searching against Mpro

The worldwide pandemic of coronavirus disease 2019 (COVID-19) along with the various newly discovered major SARS-CoV-2 variants, including B.1.1.7, B.1.351, and B.1.1.28, constitute the Variant of Concerns (VOC). It's difficult to keep these variants from spreading over the planet. As a result...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hassam, Muhammad, Bashir, Muhammad Arslan, Shafi, Sarah, Zahra, Noor-ul-Ain, Khan, Kanwal, Jalal, Khurshid, Siddiqui, Hina, Uddin, Reaz
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9635257/ https://www.ncbi.nlm.nih.gov/pubmed/36370580 http://dx.doi.org/10.1016/j.compbiomed.2022.106284

Ejemplares similares

Immunoinformatic-guided designing of multi-epitope vaccine construct against Brucella Suis 1300
por: Jalal, Khurshid, et al.
Publicado: (2022)

Identification of a Novel Therapeutic Target against XDR Salmonella Typhi H58 Using Genomics Driven Approach Followed Up by Natural Products Virtual Screening
por: Jalal, Khurshid, et al.
Publicado: (2021)

Immunoinformatic approach for the construction of multi-epitopes vaccine against omicron COVID-19 variant
por: Khan, Kanwal, et al.
Publicado: (2022)

Reverse vaccinology approach for multi-epitope centered vaccine design against delta variant of the SARS-CoV-2
por: Jalal, Khurshid, et al.
Publicado: (2022)

Comparative Metabolic Pathways Analysis and Subtractive Genomics Profiling to Prioritize Potential Drug Targets Against Streptococcus pneumoniae
por: Khan, Kanwal, et al.
Publicado: (2022)

Re-purposing of hepatitis C virus FDA approved direct acting antivirals as potential SARS-CoV-2 protease inhibitors
por: Uddin, Reaz, et al.
Publicado: (2022)

Selection of Multi-Drug Targets against Drug-Resistant Mycobacterium tuberculosis XDR1219 Using the Hyperbolic Mapping of the Protein Interaction Network
por: Zahra, Noor ul Ain, et al.
Publicado: (2023)

Pangenome diversification and resistance gene characterization in Salmonella Typhi prioritized RfaJ as a significant therapeutic marker
por: Khan, Kanwal, et al.
Publicado: (2023)

Discovering potent inhibitors against the Mpro of the SARS-CoV-2. A medicinal chemistry approach
por: Mehmood, Aamir, et al.
Publicado: (2022)

Identification of vaccine and drug targets in Shigella dysenteriae sd197 using reverse vaccinology approach
por: Jalal, Khurshid, et al.
Publicado: (2022)

Deciphering the Potential of Pre and Pro-Vitamin D of Mushrooms against Mpro and PLpro Proteases of COVID-19: An In Silico Approach
por: Tiwari, Abhay, et al.
Publicado: (2022)

In Silico Identification and Evaluation of Leads for the Simultaneous Inhibition of Protease and Helicase Activities of HCV NS3/4A Protease Using Complex Based Pharmacophore Mapping and Virtual Screening
por: Wadood, Abdul, et al.
Publicado: (2014)

In Silico Investigation of a Chimeric IL24-LK6 Fusion Protein as a Potent Candidate Against Breast Cancer
por: Muhammad Rehman, Hafiz, et al.
Publicado: (2023)

Hemi-Babim and Fenoterol as Potential Inhibitors of MPro and Papain-like Protease against SARS-CoV-2: An In-Silico Study
por: Alzamami, Ahmad, et al.
Publicado: (2022)

Subtractive genomics profiling for potential drug targets identification against Moraxella catarrhalis
por: Ashraf, Bilal, et al.
Publicado: (2022)

Identification of Therapeutic Targets in an Emerging Gastrointestinal Pathogen Campylobacter ureolyticus and Possible Intervention through Natural Products
por: Khan, Kanwal, et al.
Publicado: (2022)

In silico studies on stilbenolignan analogues as SARS-CoV-2 Mpro inhibitors
por: Cetin, Adnan
Publicado: (2021)

Isoniazid Conjugated Magnetic Nanoparticles Loaded with Amphotericin B as a Potent Antiamoebic Agent against Acanthamoeba castellanii
por: Iqbal, Kawish, et al.
Publicado: (2020)

De Novo design of potential inhibitors against SARS-CoV-2 Mpro
por: Li, Shimeng, et al.
Publicado: (2022)

Multi-conformation representation of Mpro identifies promising candidates for drug repurposing against COVID-19
por: Paul, Debarati, et al.
Publicado: (2021)

Synthesis, characterization, computational analyses, in silico ADMET studies, and inhibitory action against SARS-CoV-2 main protease (Mpro) of a Schiff base
por: ŞAHİN, Songül, et al.
Publicado: (2022)

Recognition of Natural Products as Potential Inhibitors of COVID-19 Main Protease (Mpro): In-Silico Evidences
por: Narkhede, Rohan R., et al.
Publicado: (2020)

Integrated bioinformatics based subtractive genomics approach to decipher the therapeutic function of hypothetical proteins from Salmonella typhi XDR H-58 strain
por: Khan, Kanwal, et al.
Publicado: (2022)

Structure-based screening of novel lichen compounds against SARS Coronavirus main protease (Mpro) as potentials inhibitors of COVID-19
por: Joshi, Tanuja, et al.
Publicado: (2020)

In silico screening, SAR and kinetic studies of naturally occurring flavonoids against SARS CoV-2 main protease
por: Imran, Muhammad, et al.
Publicado: (2022)

Antiamoebic activity of plant-based natural products and their conjugated silver nanoparticles against Acanthamoeba castellanii (ATCC 50492)
por: Anwar, Areeba, et al.
Publicado: (2020)

Natural Products-Based Drug Design against SARS-CoV-2 Mpro 3CLpro
por: Silva, Rai C., et al.
Publicado: (2021)

Pan-Genome Reverse Vaccinology Approach for the Design of Multi-Epitope Vaccine Construct against Escherichia albertii
por: Jalal, Khurshid, et al.
Publicado: (2021)

Impact of Coating of Urea with Bacillus-Augmented Zinc Oxide on Wheat Grown under Salinity Stress
por: Ain, Noor Ul, et al.
Publicado: (2020)

Triazolothiadiazoles and Triazolothiadiazines as New and Potent Urease Inhibitors: Insights from In Vitro Assay, Kinetics Data, and In Silico Assessment
por: Uddin, Jalal, et al.
Publicado: (2023)

Integrated Bioinformatics-Based Subtractive Genomics Approach to Decipher the Therapeutic Drug Target and Its Possible Intervention against Brucellosis
por: Khan, Kanwal, et al.
Publicado: (2022)

Effectiveness of Natural Antioxidants against SARS-CoV-2? Insights from the In-Silico World
por: Rehman, Muhammad Fayyaz ur, et al.
Publicado: (2021)

Genome Subtraction and Comparison for the Identification of Novel Drug Targets against Mycobacterium avium subsp. hominissuis
por: Uddin, Reaz, et al.
Publicado: (2020)

In silico screening of potent bioactive compounds from honeybee products against COVID-19 target enzymes
por: Shaldam, Moataz A., et al.
Publicado: (2021)

Isolation and In Silico Prediction of Potential Drug-like Compounds with a New Dimeric Prenylated Quinolone Alkaloid from Zanthoxylum rhetsa (Roxb.) Root Extracts Targeted against SARS-CoV-2 (Mpro)
por: Zohora, Fatema Tuz, et al.
Publicado: (2022)

In Silico Evaluation of Binding of 2-Deoxy-D-Glucose with Mpro of nCoV to Combat COVID-19
por: Raman, Anirudh Pratap Singh, et al.
Publicado: (2022)

In silico elucidation of potential drug targets against oxygenase domain of Human eNOS Dysfunction
por: Malik, Abbeha, et al.
Publicado: (2023)

In Vivo and In Silico Assessment of the Cardioprotective Effect of Thymus linearis Extract against Ischemic Myocardial Injury
por: Malik, Abdul, et al.
Publicado: (2022)

In-silico studies of inhibitory compounds against protease enzymes of SARS-CoV-2
por: Khan, Saba, et al.
Publicado: (2023)

Insights into the inhibitory potential of selective phytochemicals against Mpro of 2019-nCoV: a computer-aided study
por: Rasool, Nouman, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_sb4f0i0n8e117hquif409e33km